(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Ascl1 facilitates restriction of progenitor cells to the neuronal
lineage during neurogenesis. Ascl1-CreERTM;R26R-YFP
transgenic spinal cords, either Ascl1 wild-type (A-F) or
Ascl1 null (A'-F'), were examined at E17.5
after tamoxifen induction of Cre at E10.5. Double-label immunofluorescence for
YFP (green) and for markers of neurons (NeuN; A,A'), oligodendrocytes
(Sox10; B,B'), astrocytes (GFAP; C,C'), neural progenitors or
astrocytes (Glast; D,D'), oligodendrocyte progenitors (Olig2;
E,E') or proliferation (BrdU incorporation; F,F'). The fate of
E10.5 Ascl1-expressing cells shifts from almost exclusively neurons
(A, arrowheads) to cells with astrocytic or immature markers such as GFAP,
Glast, Olig2 and BrdU in the Ascl1 null (C'-F',
arrowheads). Quantification of these experiments is shown in the graph as the
percentage of the total YFP-expressing cells that coexpress each marker. At
least nine sections from three different embryos of each genotype were used.
This resulted in over 350 total YFP+ cells counted in experiments for each
marker.